This Iowa bill (SF 210) requires health licensing boards to check national databases (including child abuse and sex offender registries) before issuing licenses, denying licenses if matches are found. It mandates creation of a public online database tracking disciplinary actions, especially for sexual misconduct, substance use, or medical malpractice. The bill requires immediate license suspension for sexual misconduct or assault allegations and a 10-year waiting period plus treatment for those with founded cases. It directly affects all health professionals (doctors, nurses, etc.) seeking or holding licenses in Iowa by tightening background checks, reporting duties, and disciplinary timelines.
This bill (SF 117) protects pharmacists and licensed healthcare practitioners (like doctors, nurses, and dentists) from employer or licensing board restrictions that interfere with their professional judgment when prescribing, dispensing, or administering medications. It prohibits boards or employers from creating rules that deter professionals from using treatments they deem appropriate based on their expertise and scope of practice. Any such restriction - whether in contracts, handbooks, or policies - is declared unenforceable and cannot lead to disciplinary action. The bill ensures professionals using medication decisions within their scope and best judgment cannot face license discipline for those choices.
HF 409 prohibits hospitals and health care licensing boards in Iowa from asking applicants about past mental illness, substance use disorders, or other behavioral health diagnoses on clinical privilege or license applications. It allows questions only about current, untreated conditions that could impair safe, professional practice. The bill directly affects health care professionals applying for hospital clinical privileges or state licenses. It requires the state department to create rules enforcing these changes, focusing on current safety concerns rather than historical health conditions. The bill is currently under review by the House Health and Human Services subcommittee.
SSB 1121 creates an "emeritus license" for physicians and osteopathic physicians aged 60+ who primarily train resident doctors. The license allows them to maintain their full scope of practice without needing continuing education credits, lasts three years (with one renewal), and costs half the standard license fee. It requires board approval and an application, with the Iowa Board of Medicine defining "primarily engaged in supervising and training residents." This bill directly affects senior physicians transitioning to teaching roles, not active clinical practice.
SF 467 establishes licensing requirements for anesthesiologist assistants in Iowa. The bill requires individuals to complete an accredited education program, pass a certification exam, and obtain a license from the Board of Medicine to practice or use the title "anesthesiologist assistant" (including abbreviations "A.A." or "C.A.A."). It defines key terms like "anesthesiologist assistant" and "supervising anesthesiologist," and creates a new section (148K) outlining the board's authority to grant, deny, and renew licenses. This directly affects anesthesiologist assistants seeking to legally practice in Iowa and ensures standardized training and oversight.
This bill prohibits Iowa from issuing or renewing licenses for hospitals or healthcare facilities to entities tied to the Chinese government, Chinese citizens, or businesses with majority Chinese government ownership. It directly affects Chinese government entities, Chinese citizens, and Chinese-owned businesses seeking to establish or operate healthcare facilities in Iowa. The key mechanism requires the Iowa Department of Inspections, Appeals, and Licensing to deny licenses for such entities under the state's healthcare facility licensing rules. The bill does not ban Chinese individuals or businesses from operating healthcare services generally, only those meeting the specific ownership or government ties criteria.
This bill creates an interstate agreement allowing podiatrists to more easily practice across participating states. It establishes a process for obtaining an "expedited license" in other compact states if a podiatrist already holds a full, unrestricted license in one state and meets specific requirements (like passing exams and having no recent criminal offenses related to their practice). Crucially, it requires podiatrists to be licensed in the state where the patient is located during treatment, ensuring patient safety under that state's regulations. The law adds this new pathway for license portability but does not change existing state licensing rules for those who choose not to use the compact.
HF 556 requires health insurers in Iowa to respond to credentialing requests from physicians, advanced nurse practitioners, and physician assistants within 56 calendar days. If an application is denied, insurers must provide a written explanation. Denied applicants can appeal internally and then to the insurance division, with "network adequacy" specifically listed as a valid appeal reason. The bill was introduced in 2025 but was withdrawn on March 21, 2025, and did not become law.
HF 930 creates an interstate agreement (compact) allowing podiatrists licensed in one participating state to more easily obtain licenses in other participating states. It establishes a "state of principal license" (where the doctor primarily practices or resides) and streamlines additional state licenses through a standardized process. Podiatrists must meet all requirements - including background checks and current licensure in their principal state - but existing state laws remain unchanged. The compact ensures doctors are licensed in the state where the patient is located during treatment, prioritizing patient safety without altering individual states' core licensing authority.
HF 990 establishes a licensing process for medical cannabidiol (CBD) dispensaries in Iowa. The bill requires the state department to issue requests for proposals and license up to five dispensaries (with potential for up to ten) by April 1, 2018, and renew licenses by December 1 each year. It directly affects businesses seeking to operate medical CBD dispensaries by setting caps on the number of licenses and defining the application timeline. The key provision is the structured annual licensing system to regulate the distribution of medical CBD products within the state.
